1. Home
  2. Browse
  3. HRA007966
HRA007966
   HRA007966.xlsx
Title:
Gefitinib plus anlotinib for untreated, EGFR-mutated, advanced NSCLC (FL-ALTER): A multicenter phase III trial
Release date:
2024-07-18
Description:
Blood samples for ctDNA analysis were collected from each patient at baseline, first evaluation, and PD.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA027651
Study type:
Cohort Study
Disease name:
non-small cell lung carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000235
DAC name:
Li zhang
Contact person:
Zhang Li
Email:
zhangli@sysucc.org.cn
Description:
Professor Li zhang is responsible for data release
Individuals & samples
Files
Request Data
Submitter:   Zhang Li / zhangli@sysucc.org.cn
Organization:   Sun Yat-sen University Cancer Center
Submission date:   2024-07-02
Requests:   -